Palatin Clinical Site 278 — Lincoln, Rhode Island

Palatin Clinical Site 278 is a clinical research site located in Lincoln, Rhode Island, United States 02865.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Palatin Clinical Site 278 has participated in 1 clinical trials.

Therapeutic areas: Hypoactive Sexual Desire Disorder.

Sponsors: Palatin Technologies, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lincoln

Browse all research sites in Rhode Island · View every site in Lincoln

• Lincoln Research
• Research Site
• Ocean State Clinical Research Partners
• GSK Investigational Site
• Pfizer Investigational Site
• BTC of Lincoln
• Novartis Investigative Site
• AAPRI Clinical Research Institute
• Forest Investigative Site 059
• Alkermes Investigational Site
• Ocean St Clin Res Partnrs, LLC
• Forest Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Palatin Clinical Site 278?

Palatin Clinical Site 278 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Palatin Clinical Site 278 conducted?

Palatin Clinical Site 278 has 1 clinical trials on record. Their work covers Hypoactive Sexual Desire Disorder.

Is Palatin Clinical Site 278 accredited by Crixeo Clinical Trials?

Palatin Clinical Site 278 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Palatin Clinical Site 278?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.